Sjogren’s Syndrome Plasma
About: Sjogren's Syndrome Plasma - Cryopreserved human Sjogren's Syndrome plasma collected from clinically confirmed Sjogren's Syndrome donors. Sjogren's Syndrome plasma is ideal for characterizing biomarkers of inflammation and immune activation. Bulk plasma is available.
| Lot # | Condition | Volume | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 74299 | Sjogren's Syndrome | 1.0 ML | Caucasian | 66 | Female |
ROSUVASTATIS, Naltrexone, Ursodiol, OHA (not in MRs), BECTERVY (not in MRs), MULTIVITAMIN, CALCIUM, B COMPLEX, VIT D Lasix History of cellcept
|
16 | $316.00 | ||
| 74269 | Sjogren's Syndrome | 1.0 ML | Hispanic/Latino | 52 | Female |
Dexilant 30 mg QD Reglan 10mg BID Famotidine 40 mg QD Progesterone 200 mg QD
|
25 | $316.00 | ||
| 74596 | Sjogren's Syndrome | 1.0 ML | Caucasian | 64 | Female | United States (US) |
Hydroxychloroquine, not sure dose Potassium 30meqs 2 times daily Allopurinol, not sure dose stopped plaquenil jan 2020
|
25 | $316.00 | |
| 74585 | Sjogren's Syndrome | 1.0 ML | Hispanic/Latino | 49 | Female | United States (US) |
Eye drops Multivitamin Cevemaline 30 mg TID Lexapro 20 mg QD
|
13 | $316.00 | |
| 74427 | Sjogren's Syndrome | 1.0 ML | Caucasian | 63 | Female | United States (US) |
Atorvastatin 20 mg Omeprazole 40 mg Levothyroxine 88 mcg Trazadone 50 mg Nortriptyline 10 mg Singulair 10 mg Cymbalta 50 mg Vitamin C Methotrexate 2.5 mg Adderall XR 30 mg BID Vivitrol QM-Has not taken since November Collagen Keratin Multivitamin (Cerefolin - Brain Food) Prazosin 1mg QD
|
22 | $316.00 | |
| 74124 | Sjogren's Syndrome | 1.0 ML | Caucasian | 25 | Female | United States (US) |
Balziva, Famotidine, Lorazepam, Diclofenac
|
19 | $316.00 | |
| 54314 | Sjogren's Syndrome | 1.0 ML | Caucasian | 71 | Female | United States (US) |
Hydroxychloroquine 200 mg QD Aspirin 81 mg QD Nasal Spray PRY Cyclosporine eye drops Mirtavatine 7.5 mg QD
|
2 | $316.00 | |
| 52951 | Sjogren's Syndrome | 1.0 ML | Caucasian | 59 | Female | United States (US) |
Losartan/HCT 100-12.5 mg QD Pantoprazole 40 mg QD Famotidine 40 mg QD Amlodipine 5 mg QD Albuterol HFA 90 mcg PRN multivitamin QD iron 65 mg QD triple chlorophyll w/ phytonutrients QD black elderberry 1000 mg QD Xiidra eye drops
|
2 | $316.00 |
Sjogren’s Syndrome Plasma | High-Quality Human Plasma from Sjogren’s Syndrome Donors
Sjogren’s Syndrome Plasma is collected from donors clinically diagnosed with Sjogren’s Syndrome and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research focused on understanding biomarkers role in inflammation, immune activation, and disease activity. Bulk plasma is available.
Product Features
- Research Use Only (RUO)
- Plasma collected from clinically confirmed Sjogren’s Syndrome donors
- Processed within one day of collection
- IRB-approved protocols and informed consent
- Custom aliquot volumes available upon request
De-identified Donor Data
- Verified Sjogren’s Syndrome diagnosis
- Demographic data: age, sex assigned at birth, race/ethnicity
- Donor-reported medications, allergies, and comorbidities
- Additional Sjogren’s Syndrome-specific metadata available
Applications
- Biomarker discovery and validation
- Cytokine and inflammation profiling
- Metabolomics and proteomics studies
- Therapeutic response research
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Sjogren’s Syndrome plasma is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Protocols & Documentation
-
Download
Plasma Isolation
Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Plasma
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – with the exception of GMP leukopaks, all our products are research use only (RUO).
1 Answer
Our complete catalog can be found here: https://sanguinebio.com/products/
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective colleciton services to tailored to fit your research. For more information and request a quote, please see: https://sanguinebio.com/prospective-biospecimen-collection-services/
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: https://sanguinebio.com/quality-and-compliance/
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Plasma cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.